Metropolitan Life Insurance Company (MetLife)’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-3,719
| Closed | -$79.3K | – | 1145 |
|
2024
Q1 | $79.3K | Sell |
3,719
-408
| -10% | -$8.7K | ﹤0.01% | 1177 |
|
2023
Q4 | $59.3K | Hold |
4,127
| – | – | ﹤0.01% | 1352 |
|
2023
Q3 | $37.6K | Buy |
4,127
+606
| +17% | +$5.53K | ﹤0.01% | 1564 |
|
2023
Q2 | $37.3K | Hold |
3,521
| – | – | ﹤0.01% | 1602 |
|
2023
Q1 | $43.1K | Sell |
3,521
-629
| -15% | -$7.69K | ﹤0.01% | 1475 |
|
2022
Q4 | $51.5K | Hold |
4,150
| – | – | ﹤0.01% | 1454 |
|
2022
Q3 | $56.7K | Hold |
4,150
| – | – | ﹤0.01% | 1376 |
|
2022
Q2 | $76.1K | Hold |
4,150
| – | – | ﹤0.01% | 1228 |
|
2022
Q1 | $66.7K | Sell |
4,150
-11,444
| -73% | -$184K | ﹤0.01% | 1429 |
|
2021
Q4 | $218K | Sell |
15,594
-3,529
| -18% | -$49.4K | ﹤0.01% | 1972 |
|
2021
Q3 | $358K | Hold |
19,123
| – | – | 0.01% | 1661 |
|
2021
Q2 | $399K | Buy |
19,123
+903
| +5% | +$18.8K | 0.01% | 1672 |
|
2021
Q1 | $515K | Sell |
18,220
-598
| -3% | -$16.9K | 0.01% | 1396 |
|
2020
Q4 | $615K | Buy |
18,818
+2,171
| +13% | +$70.9K | 0.01% | 1231 |
|
2020
Q3 | $510K | Hold |
16,647
| – | – | 0.01% | 1206 |
|
2020
Q2 | $271K | Buy |
16,647
+6,447
| +63% | +$105K | ﹤0.01% | 1611 |
|
2020
Q1 | $101K | Buy |
10,200
+626
| +7% | +$6.23K | ﹤0.01% | 2020 |
|
2019
Q4 | $132K | Sell |
9,574
-1,010
| -10% | -$13.9K | ﹤0.01% | 2170 |
|
2019
Q3 | $161K | Buy |
10,584
+946
| +10% | +$14.4K | ﹤0.01% | 2028 |
|
2019
Q2 | $190K | Hold |
9,638
| – | – | ﹤0.01% | 1922 |
|
2019
Q1 | $160K | Hold |
9,638
| – | – | ﹤0.01% | 2051 |
|
2018
Q4 | $135K | Hold |
9,638
| – | – | ﹤0.01% | 2079 |
|
2018
Q3 | $169K | Buy |
9,638
+2,004
| +26% | +$35.1K | ﹤0.01% | 2127 |
|
2018
Q2 | $139K | Buy |
7,634
+490
| +7% | +$8.92K | ﹤0.01% | 2153 |
|
2018
Q1 | $134K | Hold |
7,144
| – | – | ﹤0.01% | 2135 |
|
2017
Q4 | $109K | Sell |
7,144
-7,424
| -51% | -$113K | ﹤0.01% | 2258 |
|
2017
Q3 | $218K | Buy |
+14,568
| New | +$218K | ﹤0.01% | 2224 |
|